Speaker: Brit Mollenhauer

Time is brain in Parkinson's disease

Analysis of neurotransmitter metabolites in CSF in Parkinson's Disease

Challenges hampering clinical utility of fluid biomarkers in Parkinson’s disease

The current use of biomarkers in Parkinson’s disease

Nutritional intervention studies to influence the gut microbiome and improve Parkinson’s disease

Gut dysbiosis in Parkinson’s disease

Successes in Parkinson’s disease: seeding assays and neurofilament light chains

Werner Poewe, EAN 2019 – Beyond motor wearing-OFF: What have we learned?

A biological definition and integrated staging system for Parkinson’s disease

Elena Moro, IAPRD 2018 – Highlights from the Congress Chair (Part 1)

Could Prasinezumab be reducing motor progression in the PASADENA Open-Label Extension? -Rallying 23

Piva Vs Border Voices Gaudete

Prof Bas Bloem presents 'The importance of nutrition in managing Parkinson's disease'

Body dysmorphic disorder -BDD, Mental Health Videos with Rebeckah Vaughan

Josh Hawley Humiliates Biden Energy Grifter - He Is Exposed!

Parkinson’s Disease: Into the Future | Dr. Robert Hauser

Interview with Dan Miller - Founder and CEO, Young Professionals UK

LEBENSGEFAHR T3CHNO! Die Zweite Auflage 2.0 Aftermovie met o.a. Henzel & Disconova en Paul Cairo

The Wiley Analytical Science Virtual Conference April 28, 2021.

How to Pronounce Shemozzle

microTAStic: Joachim Spatz on Synthetic Cells; Opening by Federico Nebuloni on Microenvironments

visit shbcf.ru